An open label, single arm, multi-centered study to evaluate the efficacy, safety and tolerability of lipid based tacrolimus ointment 0.1% in patients of oral lichen planus
Latest Information Update: 03 Jul 2019
At a glance
- Drugs Tacrolimus (Primary)
- Indications Lichen planus
- Focus Therapeutic Use
- Sponsors Intas Pharmaceuticals
- 30 Apr 2018 Status changed from not yet recruiting to completed.
- 07 Sep 2016 New trial record